Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine
The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.
Federal court strikes down FTC mergers and acquisitions reporting rule
A U.S. District Court in Texas ruled that the agency overstepped its regulatory authority in passing the 2024 Biden-era reporting requirement, which would require stakeholders to spend more than 100 hours filling out a long form to give the agency more oversight of transactions.
FDA investigating outbreak of ‘extensively’ antibiotic resistant salmonella linked to supplement
Capsules of moringa tree leaf, branded as Rosabella, are being recalled after seven states report cases of the illness, with three patients saying they took the supplement. The company has issued an emergency recall.
FDA approves medical device for pancreatic cancer therapy—the first new treatment in 30 years
Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.
Baxter cuts 90 jobs from IV solutions site once devastated by Hurricane Helene
The facility near Asheville, North Carolina, was shut down after floodwater from the 2024 hurricane left its production lines inoperable. It took the company roughly five months to resume normal operations—and now it’s seeing a slowdown in demand in wake of the supply chain disruption.

AIM Coalition Welcomes New Study On Self Referral in Surgical Pathology Services

A new study by Georgetown's Dr. Jean Mitchell shows that self-referral for prostate biopsy pathology evaluations has increased Medicare billing, but has not improved cancer detection.

ASNC Releases Dose-Reduction Guidelines for Nuclear Cardiology

Technological improvements in image acquisition and software processing in nuclear cardiology should allow physicians to shave patient imaging times dramatically or cut radiation doses fourfold, according to a new preferred practice statement from the American Society of Nuclear Cardiology (ASNC).

Radiologists Urge Modifications To Meaningful Use Draft Guidelines

Representatives from five medical specialties—radiologists among them—last week offered their final proposed changes to the draft guidelines for Stage 2 of the U.S. government's Meaningful Use Stimulus Program. The contingent of physicians—who aside from radiologists included pathologists, ophthalmologists, surgeons, and specialists in the areas of

ACR, ARRS to Restructure Strategic Integration

The American College of Radiology (ACR) and the American Roentgen Ray Society (ARRS) yesterday announced plans to restructure a strategic integration initiated 20 months ago into to a “strategic alliance.”

Be Mindful of the Stark Law in CCTA Alliances

Numerous radiology groups are currently discussing arrangements whereby cardiologists and the radiologists would essentially split the responsibilities for reading coronary CT angiography (CCTA) studies. Most commonly, as proposed, the cardiologists would read and generate a signed interpretation report, but limited to the cardiac portion of the

Business Intelligence

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

Federal court strikes down FTC mergers and acquisitions reporting rule

FDA investigating outbreak of ‘extensively’ antibiotic resistant salmonella linked to supplement

FDA approves medical device for pancreatic cancer therapy—the first new treatment in 30 years

Baxter cuts 90 jobs from IV solutions site once devastated by Hurricane Helene